Despite normal initial activation of autoreactive CD4+ T cells, potentially autoreactive B cells in knockout (KO) allele within the B6 background to KRN/B6 mice and also to B6

Despite normal initial activation of autoreactive CD4+ T cells, potentially autoreactive B cells in knockout (KO) allele within the B6 background to KRN/B6 mice and also to B6.g7. (53-6.7), CD11b (M1/70), CD11c (N418), CD16/32 (clone93), CD19 (1D3), CD23 (B3B4), CD38 (clone90), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD73 Chaetominine (ebioTy/11.8), CD90.1 (HIS51), F4/80 (BM8), Foxp3 (FJK-16s), FR4 (ebio12A5), Gr-1 (RB6-8C5), GL7-ef450, H-2Kb (AF6-88.5.5.3-PE), H-2Kd (SF1-1.1.1), IgD (11-26c), IgG1 (M1-14D12), IgM (eB121-15F9), Ki67 (SolA15), MHCII (M5/114.15.2), and PD-1 (J43). The following antibodies were purchased from BD Pharmingen: CD3 (500A2), CD24 (M1/69), CD90.2 (53-2.1), CXCR5 (2G8), GL7-FITC, H-2Kb (AF6-88.5-FITC), IgM (II/41), and TCR V6 (RR4-7). Anti-CD4 (RM4-5, BioLegend) was used in some experiments. Intracellular staining using anti-Foxp3 (FJK-16s), IgG1 (RMG101, Invitrogen), and IgG (H+L) F(ab)2 (Invitrogen) was performed using intracellular permeabilization/fixation reagents (eBioscience) per the manufacturers protocol. GPI-PE and GPI-AF647-PE tetramers have been explained previously (20). Circulation cytometry was performed using an LSRII or an LSRFortessa (BD Biosciences), and cells were analyzed using FlowJo v8.8.7 software (Tree Star). The gating plan for all experiments included 1st using ahead and part scatter along with Fixable Viability Dye (eBioscience) to identify live, singlet lymphocytes. Subsequent gating Chaetominine guidelines are explained in the Numbers and Legends. Immunofluorescent staining After obstructing Fc receptors with 2.4G2 (BD Pharmingen) and anti-CD64 (clone N19, SantaCruz) antibodies and blocking biotin with an avidin/biotin blocking kit (Vector Laboratories), frozen sections were stained with fluorescently-conjugated antibodies recognizing CD3, TCR (H57-597, BD Pharmingen), and biotinylated anti-B220 plus SA-DyLight 550 (Thermo Fisher Scientific). DAPI was used to detect nuclei. Slides were viewed on an Olympus BX51 fluorescent microscope equipped with a digital video camera and DP-BSW software (Olympus). Ag-specific B cell enrichment GPI-specific B cells were enriched as explained (20). Briefly, pooled lymph node cells and splenocytes were incubated with the Ag-specific GPI-PE and Ag-nonspecific C5A-AF647-PE (decoy) tetramers, followed by incubation with anti-PE magnetic microbeads, after which the cells were approved through a magnetic column and both the Ag-specific B cell-enriched (bound) and polyclonal (unbound) fractions were collected. Plau Both fractions were then labeled having a cocktail of fluorescent B cell and non-B cell markers for circulation Chaetominine cytometric analysis. Assessment of arthritis and IgG titers Arthritis was assessed via medical rating and ankle Chaetominine measurements, and total serum IgG and anti-GPI titers were determined as explained (21, 22). Serum-transferred arthritis Pooled serum (150 L/dose) from K/BxN mice was injected intraperitoneally into recipient mice on days 0 and Chaetominine 2 (14). The mice were monitored for the development of arthritis for 2 weeks as explained above. Anti-GPI IgG ELISPOT Splenocytes were analyzed via ELISPOT to examine autoantibody production on a per-cell basis as previously explained (23). ELISPOT plates were read using an ImmunoSpot (Cellular Technology, Ltd). Intracellular cytokine staining Lymph node cells were isolated, stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin, and stained intracellularly for IL-17 and IFN as explained (24). Ag uptake by macrophages Peritoneal macrophages were elicited by intraperitoneal injection of 1 1 mL Brewer thioglycollate medium (Fluka Analytical). Macrophages were collected 5 days later on via peritoneal lavage, incubated with 5 g GPI or BSA labeled with AF647 (Existence Systems) in total press for 20 moments at 37C/5% CO2, washed, and analyzed by circulation cytometry. European blotting Serum samples were separated by SDS-PAGE and transferred to Immobilin-FL membranes (Millipore). GPI was recognized using serum from K/BxN mice, followed by peroxidase-conjugated goat anti-mouse IgG1 (Jackson Immunoresearch), developed with ECL Primary Western Blotting Detection Reagent (GE Healthcare), and imaged quantitatively on an ImageQuant LAS4000 workstation (GE Healthcare). Because antibody weighty chain co-migrates with GPI, antibody-deficient.